Disclosures according to the German Securities Trading Act

In this section you find disclosures according to the German Securities Trading Act (WpHG)

• Ad hoc releases of STADA Arzneimittel AG in accordance with § 15 WpHG
• Disclosure requirements according to § 15a WpHG
  (Director's Dealings-Service of DGAP)
• Total number of voting rights (§ 26a WpHG) (PDF)
• Publications in accordance with § 26 WpHG of the financial year 2008 (PDF)
• Publications in accordance with § 26 WpHG of the financial year 2009 (PDF)
• Publications in accordance with § 26 WpHG of the financial year 2010 (PDF)
• Publications in accordance with § 26 WpHG of the financial year 2011 (PDF)
• Publications in accordance with § 26 WpHG of the financial year 2012 (PDF)
• Publications in accordance with § 26 WpHG of the financial year 2013 (PDF)

In addition, the Annual Document 2011 pursuant to paragraph 10 section 1 WpPG (Securities Prospectus Act) and the single-entity Financial Statements 2012 of STADA Arzneimittel AG (PDF) can be viewed here.